Spot Biosystems
Develops non-viral gene therapy using extracellular vesicle delivery platform for genetic medicines
$40MSeries B
Role not disclosedSV
Shanda Ventures
Activity from announced rounds
Activity in this selectionsymbolic-capital-f3f73206
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $40M 1 disclosed · full round size, not this investor’s share